Navigation Menu

Portals Internet Clinical Trial External Search

Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Portals Internet Researcher Display

Thomas Riley III, MD, MS

Thomas Riley III, MD, MS

Professor, Department of Medicine
Division of Gastroenterology and Hepatology
Disease Teams:
Cancer Institute, Liver, Pancreas and Foregut Cancer Team

Research Interests

  • Therapeutics
  • Liver
  • Liver Diseases
  • Liver Transplantation
  • Chronic Disease
  • Antiviral Agents
  • Hepatitis C
  • Chronic Hepatitis C
  • Hepacivirus
  • Fibrosis
  • Medicare
  • Biopsy

Recent Publications


Tran, L, Jung, J, Feldman, R & Riley, T 2022, 'Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries', PloS one, vol. 17, no. 3 March, e0263913.
Stine, JG, Schreibman, IR, Faust, AJ, Dahmus, J, Stern, B, Soriano, C, Rivas, G, Hummer, B, Kimball, SR, Geyer, NR, Chinchilli, VM, Loomba, R, Schmitz, K, Sciamanna, C, Strine, C, Wentzel, R, Marlin, S, Sica, C, Vesek, J, Eyster, E, Sinoway, L, Bentz, K, Handley, N, Hershey Fell, B, Mottilla, S, Christ, C, George, S, Novchich, T, Beyer, M, Clarke, K, Myers, T, Glading-Steinruck, M, Krok, K, Ma, T, Riley, T, Thompson, E, Tressler, H, Broach, J, Doan, T, Patrick, S, Reed, S, Hamilton, C, Slavoski, K & Tregea, D 2022, 'NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH', Hepatology, vol. 76, no. 1, pp. 172-185.


Tran, L, Feldman, R, Riley, T & Jung, J 2021, 'Association of the Extension for Community Healthcare Outcomes Project with Use of Direct-Acting Antiviral Treatment among US Adults with Hepatitis C', JAMA network open, vol. 4, no. 7, e2115523.
Du, P, Wang, X, Kong, L, Riley, T & Jung, J 2021, 'Changing Urban–Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014–2017', American Journal of Preventive Medicine, vol. 60, no. 2, pp. 285-293.
Kadry, Z, Schaefer, E, Krok, K, Faust, A, Stine, JG, Schreibman, IR, Bezinover, D & Riley, TR 2021, 'Excellent outcomes with liver transplantation in hepatopulmonary syndrome across pre-transplant PaO2 spectrum', JHEP Reports, vol. 3, no. 5, 100351.
Roy, J, Kang, M, Stern, B, Riley, T & Schreibman, I 2021, 'Lactulose-induced pneumatosis intestinalis following colonoscopy: a case report', Clinical Journal of Gastroenterology, vol. 14, no. 4, pp. 1152-1156.
Du, P, Jung, J, Kalidindi, Y, Farrow, K, Riley, T & Whitener, C 2022, 'Low utilization of direct-acting antiviral agents in a large national cohort of HIV and HCV coinfected Medicare patients in the United States: Implications for HCV elimination', Journal of Public Health Management and Practice, vol. 28, no. 2, pp. 130-134.
Noverati, N, Federici, E & Riley, TR 2021, 'Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?', Transfusion, vol. 61, no. 3, pp. 708-712.
Kadry, Z, Stine, JG, Dohi, T, Jain, A, Robyak, KL, Kwon, O, Hamilton, CJ, Janicki, P, Riley, TR, Butt, F, Krok, K, Schreibman, IR, Bezinover, D, Ghahramani, N, Campos, S & Hollenbeak, CS 2021, 'Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial', Transplantation Direct, vol. 7, no. 7, pp. E709.


Jung, J, Feldman, R, Kalidindi, Y & Riley, T 2020, 'Association of Direct-Acting Antiviral Therapy for Hepatitis C With After-Treatment Costs Among Medicare Beneficiaries', JAMA network open, vol. 3, no. 6, pp. e208081.
Kalidindi, Y, Jung, J, Feldman, R & Riley, T 2020, 'Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C', JAMA network open, vol. 3, no. 7, pp. e2011055.
Jung, J, Du, P, Feldman, R & Riley, T 2020, 'Discontinuation of new hepatitis C drugs among Medicare patients', American Journal of Managed Care, vol. 26, no. 2, pp. 84-88.
Jain, A, Riley, TR, Krok, KL, Schreibman, I, Karamchandani, DM, Liao, X, Tian, Y, Dohi, T & Kadry, Z 2020, 'Incidence of post-liver transplant hepatic dysfunction after sustained virologic response following direct-acting anti-hepatitis c therapy', Experimental and Clinical Transplantation, vol. 18, no. 3, pp. 345-352.


Loloi, J, Patel, A, McDevitt, P, Bruno, MA & Riley, T 2019, 'How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver Size Correlate? A Prospective Study', American Journal of Medicine, vol. 132, no. 1, pp. 103-108.
Jain, A, Miller, D, Schreibman, I, Riley, TR, Krok, KL, Dohi, T, Sharma, R & Kadry, Z 2019, 'Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?', Hepatology International, vol. 13, no. 2, pp. 190-198.
Jung, J, Du, P, Feldman, R, Kong, L & Riley, T 2019, 'Racial/ethnic and socioeconomic disparities in use of direct-acting antivirals among Medicare beneficiaries with chronic hepatitis C, 2014-2016', Journal of Managed Care and Specialty Pharmacy, vol. 25, no. 11, pp. 1236-1242.